Published October 14, 2025 | Version v1
Journal article Open

Application of chromatographic methods for quality control of cannabinoid impurities in products containing Cannabidiol

Authors/Creators

  • 1. Medical University, Sofia, Bulgaria

Description

Strict quality control of impurities in legitimate cannabidiol products and in cannabis "novel foods" is necessary due to the increased health risks from side effects associated with these impurities. The purpose of the present study is to summarize the most common impurities found in cannabidiol products, the factors that contribute to their elevated content, and the application of chromatographic methods for quality control. Light, temperature, oxidation, acidic medium, and especially their combined effects are critical in contamination with impurities. The most common impurities include delta-9-tetrahydrocannabinol, cannabinol, cannabichromene, cannabidivarin, cannabigerol, cannabiquinone, tetrahydrocannabidivarin, cannabidiolic acid, cannabigerolic acid, and tetrahydrocannabinolic acid. For the separation and determination of permissible levels of impurities in commercial cannabidiol products, HPLC and GC methods are appropriate and reliable for enhancing quality control, as they provide high sensitivity, accuracy, and precision. The most widely used techniques are HPLC-UV, HPLC-UV-PDA, HPLC-MS, HPLC-MS/MS, UHPLC-UV, UHPLC-UV-PDA, UHPLC-MS, UHPLC-MS/MS, UHPSFC, GC-MS, and GC-FID.

Files

PHAR_article_170419.pdf

Files (541.1 kB)

Name Size Download all
md5:c68905aaa65bb3f1a89638c8ea17fee6
329.0 kB Preview Download
md5:c1722a851368bebded642bce6df1ee53
212.1 kB Preview Download

Additional details

Cites
Publication: 10.1186/s42238-020-0016-7 (DOI)
Publication: 10.1007/s10337-021-04060-9 (DOI)
Publication: 10.1016/j.therap.2023.02.006 (DOI)
Publication: 10.1002/jms.4726 (DOI)
Publication: 10.1038/s41598-022-13737-6 (DOI)
Publication: 10.1007/s11920-017-0775-9 (DOI)
Publication: 10.1007/s00280-017-3387-5 (DOI)
Publication: 10.1016/S0040-4039(00)98518-6 (DOI)
Publication: 10.1002/pca.2915 (DOI)
Publication: 10.1016/j.jep.2018.09.004 (DOI)
Publication: 10.1007/s00216-024-05396-5 (DOI)
Publication: 10.3390/plants9060725 (DOI)
Publication: 10.1016/j.talanta.2018.09.012 (DOI)
Publication: 10.1021/acs.jnatprod.9b01284 (DOI)
Publication: 10.3390/molecules28073271 (DOI)
Publication: 10.7812/TPP/20.156 (DOI)
Publication: 10.1016/j.jpba.2016.05.033 (DOI)
Publication: 10.1002/pca.2722 (DOI)
Publication: 10.1016/j.jpba.2019.06.049 (DOI)
Publication: 10.1089/can.2020.0021 (DOI)
Publication: 10.1093/ibd/izy014 (DOI)
Publication: 10.1016/j.jchromb.2009.11.004 (DOI)
Publication: 10.1111/bcpt.13997 (DOI)
Publication: 10.1002/ansa.202000091 (DOI)
Publication: 10.3389/fpls.2019.00296 (DOI)
Publication: 10.1039/C3AY41632A (DOI)
Publication: 10.5897/JMPR2023.7313 (DOI)
Publication: 10.1046/j.1432-1033.2001.02030.x (DOI)
Publication: 10.1155/2018/3057272 (DOI)
Publication: 10.3390/molecules191118781 (DOI)
Publication: 10.3389/fphar.2024.1335441 (DOI)
Publication: 10.5740/jaoacint.15-095 (DOI)
Publication: 10.1016/j.forsciint.2019.03.046 (DOI)
Publication: 10.1016/j.talo.2022.100112 (DOI)
Publication: 10.1039/c6np00074f (DOI)
Publication: 10.1111/j.2042-7158.1976.tb04153.x (DOI)
Publication: 10.1136/bmj.38267.664086.63 (DOI)
Publication: 10.1007/s10722-003-4452-y (DOI)
Publication: 10.38212/2224-6614.3370 (DOI)
Publication: 10.2174/1570159X17666190603171901 (DOI)
Publication: 10.3746/jkfn.2023.52.5.492 (DOI)
Publication: 10.1002/jssc.200500130 (DOI)
Publication: 10.1016/j.tips.2009.07.006 (DOI)
Publication: 10.1089/can.2021.0004 (DOI)
Publication: 10.3390/ijms18081739 (DOI)
Publication: 10.1016/j.forsciint.2019.110064 (DOI)
Publication: 10.38212/2224-6614.3452 (DOI)
Publication: 10.1016/j.pediatrneurol.2017.02.009 (DOI)
Publication: 10.20882/adicciones.858 (DOI)
Publication: 10.1016/j.bcab.2020.101736 (DOI)
Publication: 10.3390/ijms26010152 (DOI)
Publication: 10.1080/19440049.2020.1769200 (DOI)
Publication: 10.1002/sscp.201700005 (DOI)
Publication: 10.9758/cpn.2017.15.4.301 (DOI)
Publication: 10.3390/separations8120227 (DOI)
Publication: 10.1016/j.tips.2024.12.005 (DOI)
Publication: 10.1515/hmbci-2018-0013 (DOI)
Publication: 10.1176/appi.ajp.2017.17030325 (DOI)
Publication: 10.1111/j.1360-0443.2008.02230.x (DOI)
Publication: 10.1371/journal.pone.0196396 (DOI)
Publication: 10.1016/j.jpba.2021.114174 (DOI)
Publication: 10.1111/bcp.14038s (DOI)
Publication: 10.1001/jamaneurol.2020.0073 (DOI)
Publication: 10.3389/fphar.2020.571832 (DOI)
Publication: 10.1002/pca.2906 (DOI)
Publication: 10.1007/s11910-018-0814-x (DOI)
Publication: 10.1016/j.talanta.2013.12.044 (DOI)
Publication: 10.1016/j.jpba.2017.11.054 (DOI)
Publication: 10.1186/s42238-021-00111-y (DOI)
Publication: 10.1021/acs.jafc.0c07472 (DOI)
Publication: 10.1016/j.pnpbp.2018.08.030 (DOI)
Publication: 10.1021/acs.jnatprod.2c01008 (DOI)
Publication: 10.1093/jaoacint/qsad122 (DOI)
Publication: 10.1007/s11910-018-0859-x (DOI)
Publication: 10.3389/fneur.2017.00299 (DOI)
Publication: 10.1038/s41598-022-23910-6 (DOI)
Publication: 10.1186/s40543-022-00351-4 (DOI)
Publication: 10.1111/1556-4029.15574 (DOI)
Publication: 10.1155/2023/8825358 (DOI)
Publication: 10.1007/978-3-319-54564-6_8 (DOI)
Publication: 10.1016/j.cca.2019.01.002 (DOI)
Publication: 10.1016/bs.apha.2017.05.003 (DOI)
Publication: 10.3390/molecules27030975 (DOI)
Publication: 10.1016/j.yebeh.2018.07.020 (DOI)
Publication: 10.1007/s00482-015-0092-3 (DOI)
Publication: 10.1186/s42238-021-00062-4 (DOI)
Publication: 10.2116/analsci.20N015 (DOI)
Publication: 10.1248/cpb.c21-00901 (DOI)
Publication: 10.1038/s41598-023-33815-7 (DOI)
Publication: 10.1016/j.jpba.2021.114215 (DOI)
Publication: 10.1007/s13311-014-0304-z (DOI)
Publication: 10.1111/1556-4029.13341 (DOI)
Publication: 10.1136/bmj.324.7329.105 (DOI)
Publication: 10.3390/brainsci11091211 (DOI)
Has part
Figure: 10.3897/pharmacia.72.e170419.figure1 (DOI)

References

  • Abioye A, Ayodele O, Marinkovic A, Patidar R, Akinwekomi A, Sanyaolu A (2020) Δ9-Tetrahydrocannabivarin (THCV): a commentary on potential therapeutic benefit for the management of obesity and diabetes. Journal of Cannabis Research 2(1): 6. https://doi.org/10.1186/s42238-020-0016-7
  • Ahmed AQ, Noshad D, Li PC (2021) Quantification of cannabinoids in cultivars of Cannabis sp. by gas chromatography–mass spectrometry. Chromatographia 84(8): 711–717. https://doi.org/10.1007/s10337-021-04060-9
  • Alvarez JC, Pelissier AL, Mura P, Goullé JP (2023) Cannabidiol (CBD): Analytical and toxicological aspects. Therapie 78(6): 639–645. https://doi.org/10.1016/j.therap.2023.02.006
  • Amirav A, Neumark B, Margolin Eren KJ, Fialkov AB, Tal N (2021) Cannabis and its cannabinoids analysis by gas chromatography–mass spectrometry with Cold EI. Journal of Mass Spectrometry 56(6): e4726. https://doi.org/10.1002/jms.4726
  • Analakkattillam S, Langsi VK, Hanrahan JP, Moore E (2022) Analytical method validation for assay determination of cannabidiol and tetrahydrocannabinol in hemp oil infused products by RP-HPLC. Scientific Reports 12(1): 12453. https://doi.org/10.1038/s41598-022-13737-6
  • Babson KA, Sottile J, Morabito D (2017) Cannabis, cannabinoids, and sleep: a review of the literature. Current Psychiatry Reports 19(4): 23. https://doi.org/10.1007/s11920-017-0775-9
  • Badowski ME (2017) A review of oral cannabinoids and medical marijuana for the treatment of chemotherapy-induced nausea and vomiting: a focus on pharmacokinetic variability and pharmacodynamics. Cancer Chemotherapy and Pharmacology 80(3): 441–449. https://doi.org/10.1007/s00280-017-3387-5
  • Baek S-H, Srebnik M, Mechoulam R (1985) Boron triflouride etherate on alimina - a modified Lewis acid reagent: an improved synthesis of cannabidiol. Tetrahedron Letters 26(8): 1083–1086. https://doi.org/10.1016/S0040-4039(00)98518-6
  • Baranauskaite J, Marksa M, Ivanauskas L, Vitkevicius K, Liaudanskas M, Skyrius V, Baranauskas A (2020) Development of extraction technique and GC/FID method for the analysis of cannabinoids in Cannabis sativa L. spp. santicha (hemp). Phytochemical Analysis 31(4): 516–521.https://doi.org/10.1002/pca.2915
  • Bonini SA, Premoli M, Tambaro S, Kumar A, Maccarinelli G, Memo M, Mastinu A (2018) Cannabis sativa: a comprehensive ethnopharmacological review of a medicinal plant with a long history. Journal of Ethnopharmacology 227: 300–315. https://doi.org/10.1016/j.jep.2018.09.004
  • Brighenti V, Marani M, Caroli C, Bertarini L, Gaggiotti A, , Durante C, Cannazza G, Pellati F (2024) A new HPLC method with multiple detection systems for impurity analysis and discrimination of natural versus synthetic cannabidiol. Analytical and Bioanalytical Chemistry 416(20): 4555–4569. https://doi.org/10.1007/s00216-024-05396-5
  • Burgel L, Hartung J, Schibano D, Graeff-Hönninger S (2020) Impact of different phytohormones on morphology, yield and cannabinoid content of Cannabis sativa L. Plants 9(6): 725. https://doi.org/10.3390/plants9060725
  • Burnier C, Esseiva P, Roussel C (2019) Quantification of THC in Cannabis plants by fast-HPLC-DAD: a promising method for routine analyses. Talanta 192: 135–141. https://doi.org/10.1016/j.talanta.2018.09.012
  • Caprioglio D, Mattoteia D, Pollastro F, Negri R, Lopatriello A, Chianese G, Alberto Minassi A, Collado JA, Munoz E, Taglialatela-Scafati O, Appendino G (2020) The oxidation of phytocannabinoids to cannabinoquinoids. Journal of Natural Products 83(5): 1711–1715. https://doi.org/10.1021/acs.jnatprod.9b01284
  • Castillo-Arellano J, Canseco-Alba A, Cutler SJ, León F (2023) The polypharmacological effects of cannabidiol. Molecules 28(7): 3271. https://doi.org/10.3390/molecules28073271
  • Chayasirisobhon S (2021) The role of cannabidiol in neurological disorders. The Permanente Journal 25: 20.156. https://doi.org/10.7812/TPP/20.156
  • Citti C, Ciccarella G, Braghiroli D, Parenti C, Vandelli MA, Cannazza G (2016) Medicinal Cannabis: principal cannabinoids concentration and their stability evaluated by a high performance liquid chromatography coupled to diode array and quadrupole time of flight mass spectrometry method. Journal of Pharmaceutical and Biomedical Analysis 128: 201–209. https://doi.org/10.1016/j.jpba.2016.05.033
  • Citti C, Battisti UM, Braghiroli D, Ciccarella G, Schmid M, Vandelli MA, Cannazza G (2018) A metabolomic approach applied to a liquid chromatography coupled to high‐resolution tandem mass spectrometry method (HPLC‐ESI‐HRMS/MS): towards the comprehensive evaluation of the chemical composition of Cannabis medicinal extracts. Phytochemical Analysis 29(2): 144–155. https://doi.org/10.1002/pca.2722
  • Citti C, Linciano P, Forni F, Vandelli MA, Gigli G, Laganà A, Cannazza G (2019) Analysis of impurities of cannabidiol from hemp. Isolation, characterization and synthesis of cannabidibutol, the novel cannabidiol butyl analog. Journal of Pharmaceutical and Biomedical Analysis 175: 112752. https://doi.org/10.1016/j.jpba.2019.06.049
  • Citti C, Russo F, Linciano P, Strallhofer SS, Tolomeo F, Forni F, Vandelli MA, Gigli G, Cannazza G (2021) Origin of Δ9-tetrahydrocannabinol impurity in synthetic cannabidiol. Cannabis and Cannabinoid Research 6(1): 28–39. https://doi.org/10.1089/can.2020.0021
  • Clarke RC, Merlin MD (2016) Cannabis taxonomy: the "Sativa" vs. "Indica" debate. Herbal Gram 110: 44–49. www.herbalgram.org
  • Couch DG, Maudslay H, Doleman B, Lund JN, O'Sullivan SE (2018) The use of cannabinoids in colitis: a systematic review and meta-analysis. Inflammatory Bowel Diseases 24(4): 680–697. https://doi.org/10.1093/ibd/izy014
  • DAC/NRF, DAC C-052: Cannabidiol, NRF 22.10: Ölige Cannabidiol-Lösung 50 mg/ml, Germany, 2015.
  • De Backer B, Debrus B, Lebrun P, Theunis L, Dubois N, Decock L, Verstraete A, Hubert P, Charlier C (2009) Innovative development and validation of an HPLC/DAD method for the qualitative and quantitative determination of major cannabinoids in Cannabis plant material. Journal of Chromatography B 877(32): 4115–4124. https://doi.org/10.1016/j.jchromb.2009.11.004
  • Deewatthanawong R, Kongchinda P, Chanapan S, Tontiworachai B, Sakkhamduang C, Montri N (2023) Non-destructive measurement of Tetrahydrocannabinol (THC) and Cannabidiol (CBD) using near-infrared spectroscopy. Technology 19(6): 2413–2426. http://www.ijat-aatsea.com
  • de Fátima dos Santos Sampaio M, de Paiva YB, Sampaio TB, Pereira MG, Coimbra NC (2024) Therapeutic applicability of cannabidiol and other phytocannabinoids in epilepsy, multiple sclerosis and Parkinson's disease and in comorbidity with psychiatric disorders. Basic Clinical Pharmacology Toxicology 134(5): 574–601. https://doi.org/10.1111/bcpt.13997
  • Deidda R, Schelling C, Roussel JM, Dispas A, De Bleye C, Ziemons É, Hubert P, Veuthey JL (2021) The analysis of cannabinoids in Cannabis samples by supercritical fluid chromatography and ultra‐high‐performance liquid chromatography: a comparison study. Analytical Science Advances 2(1–2): 2–14. https://doi.org/10.1002/ansa.202000091
  • Eichhorn Bilodeau S, Wu BS, Rufyikiri AS, MacPherson S, Lefsrud M (2019) An update on plant photobiology and implications for Cannabis production. Frontiers in Plant Science 10: 296. https://doi.org/10.3389/fpls.2019.00296
  • Eiras MM, De Oliveira DN, Ferreira MS, Benassi M, Cazenave SOS, Catharino RR (2014) Fast fingerprinting of cannabinoid markers by laser desorption ionization using silica plate extraction. Analytical Methods 6(5): 1350–1352. https://doi.org/10.1039/C3AY41632A
  • Eloh K, Alfa K, Simalou O, Sanvee SCJ, Bakaï MR, Kagnou H, Caboni P (2023) Determination of tetrahydrocannabinol and cannabidiol contents in Cannabis sativa L. samples in Togo using gas chromatography-mass spectrometry. Journal of Medicinal Plants Research 17(10): 284–291. https://doi.org/10.5897/JMPR2023.7313
  • Fellermeier M, Eisenreich W, Bacher A, Zenk MH (2001) Biosynthesis of cannabinoids, incorporation experiments with 13C-labeled glucoses. European Journal of Biochemistry 268(6): 1596–1604. https://doi.org/10.1046/j.1432-1033.2001.02030.x
  • Gao C, Cheng C, Zhao L, Yu Y, Tang Q, Xin P, Liu T, Yan Z, Guo Y, Zang G (2018) Genome‐wide expression profiles of hemp (Cannabis sativa L.) in response to drought stress. International Journal of Genomics 1: 3057272. https://doi.org/10.1155/2018/3057272
  • Giacoppo S, Mandolino G, Galuppo M, Bramanti P, Mazzon E (2014) Cannabinoids: new promising agents in the treatment of neurological diseases. Molecules 19(11): 18781–18816. https://doi.org/10.3390/molecules191118781
  • Gidal BE, Vandrey R, Wallin C, Callan S, Sutton A, Saurer TB, Triemstra JL (2024) Product labeling accuracy and contamination analysis of commercially available cannabidiol product samples. Frontiers in Pharmacology 15: 1335441. https://doi.org/10.3389/fphar.2024.1335441
  • Gul W, Gul SW, Radwan MM, Wanas AS, Mehmedic Z, Khan II, Sharaf MHM, ElSohly MA (2015) Determination of 11 cannabinoids in biomass and extracts of different varieties of Cannabis using high-performance liquid chromatography. Journal of AOAC International 98(6): 1523–1528. https://doi.org/10.5740/jaoacint.15-095
  • Guy GSW, Alice MEAD, Devinsky O (2016) Use of cannabinoids in the treatment of epilepsy. GW Pharma Limited, US, 2016-04-21.
  • Hädener M, König S, Weinmann W (2019) Quantitative determination of CBD and THC and their acid precursors in confiscated Cannabis samples by HPLC-DAD. Forensic Science International 299: 142–150. https://doi.org/10.1016/j.forsciint.2019.03.046
  • Hall DR, Sinclair JS, Bhuyan DJ, Khoo C, Li CG, Sarris J, Low M (2022) Quality control of Cannabis inflorescence and oil products: response factors for the cost-efficient determination of ten cannabinoids by HPLC. Talanta Open 5: 100112. https://doi.org/10.1016/j.talo.2022.100112
  • Hanuš LO, Meyer SM, Muñoz E, Taglialatela-Scafati O, Appendino G (2016) Phytocannabinoids: a unified critical inventory. Natural Product Reports 33(12): 1357–1392. https://doi.org/10.1039/c6np00074f
  • Harvey DI (1976) Characterization of the butyl homologues of Δ1-tetrahydrocannabinol, cannabinol and cannabidiol in samples of Cannabis by combined gas chromatography and mass spectrometry. Journal of Pharmacy and Pharmacology 28(4): 280–285. https://doi.org/10.1111/j.2042-7158.1976.tb04153.x
  • Henquet C, Krabbendam L, Spauwen J, Kaplan C, Lieb R, Wittchen HU, van Os J (2005) Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. British Medical Journal 330(7481): 11. https://doi.org/10.1136/bmj.38267.664086.63
  • Hillig KW (2005) Genetic evidence for speciation in Cannabis (Cannabaceae). Genetic Resources and Crop Evolution 52(2): 161–180. https://doi.org/10.1007/s10722-003-4452-y
  • Hsu YH, Fang MC, Huang SC, Kao YM, Tseng SH, Wang DY (2021) Determination of cannabinoids in hemp oil based cosmetic products by LC-tandem MS. Journal of Food and Drug Analysis 29(3): 502. https://doi.org/10.38212/2224-6614.3370
  • Huestis MA, Solimini R, Pichini S, Pacifici R, Carlier J, Busardò FP (2019) Cannabidiol adverse effects and toxicity. Current Neuropharmacology 17(10): 974–989. https://doi.org/10.2174/1570159X17666190603171901
  • Hwang HY, Kim MJ, Shim HM, Jeong WS (2023) UPLC-MS Assessment of THC and CBD Levels of Hemp Seeds, Hemp Seed Oil, and Hemp-Based Processed Foods Distributed in South Korea. Journal of the Korean Society of Food Science and Nutrition 52(5): 492–498. https://doi.org/10.3746/jkfn.2023.52.5.492
  • Ilias Y, Rudaz S, Mathieu P, Christen P, Veuthey JL (2005) Extraction and analysis of different Cannabis samples by headspace solid-phase microextraction combined with gas chromatography mass spec­trometr. Journal of Separation Science 28(17): 2293–2300. https://doi.org/10.1002/jssc.200500130
  • Izzo AA, Borrelli F, Capasso R, Di Marzo V, Mechoulam R (2009) Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb. Trends in Pharmacological Sciences 30(10): 515–527. https://doi.org/10.1016/j.tips.2009.07.006
  • Jaidee W, Siridechakorn I, Nessopa S, Wisuitiprot V, Chaiwangrach N, Ingkaninan K, Waranuch N (2022) Kinetics of CBD, Δ9-THC degradation and cannabinol formation in Cannabis resin at various temperature and pH conditions. Cannabis and Cannabinoid Research 7(4): 537–547. https://doi.org/10.1089/can.2021.0004
  • Jakubovski E, Müller-Vahl K (2017) Speechlessness in Gilles de la Tourette syndrome: cannabis-based medicines improve severe vocal blocking tics in two patients. International Journal of Molecular Sciences 18(8): 1739. https://doi.org/10.3390/ijms18081739
  • Jang E, Kim H, Jang S, Lee J, Baeck S, In S, Kim E, Kim YU, Han E (2020) Concentrations of THC, CBD, and CBN in commercial hemp seeds and hempseed oil sold in Korea. Forensic Science International 306: 110064. https://doi.org/10.1016/j.forsciint.2019.110064
  • Jeong M, Lee S, Seo C, Kwon E, Rho S, Cho M, Kim MY, Lee W, Lee YS, Hong J (2023) Chemical transformation of cannabidiol into psychotropic cannabinoids under acidic reaction conditions: Identification of transformed products by GC–MS. Journal of Food and Drug Analysis 31(1): 165. https://doi.org/10.38212/2224-6614.3452
  • Kaplan EH, Offermann EA, Sievers JW, Comi AM (2017) Cannabidiol treatment for refractory seizures in Sturge-Weber syndrome. Pediatric Neurology 71: 18–23.e2. https://doi.org/10.1016/j.pediatrneurol.2017.02.009
  • Köguel CC, López-Pelayo H, Balcells-Olivero MM, Colom J, Gual A (2018) Psychoactive constituents of Cannabis and their clinical implications: a systematic review. Adicciones 30(2): 140–151. https://doi.org/10.20882/adicciones.858
  • Kovalchuk O, Li D, Rodriguez-Juarez R, Golubov A, Hudson D, Kovalchuk I (2020) The effect of Cannabis dry flower irradiation on the level of cannabinoids, terpenes and anti-cancer properties of the extracts. Biocatalysis and Agricultural Biotechnology 29: 101736. https://doi.org/10.1016/j.bcab.2020.101736
  • Kumar U (2025) Cannabinoids: role in neurological diseases and psychiatric disorders. International Journal of Molecular Sciences 26(1): 152. https://doi.org/10.3390/ijms26010152
  • Lee JH, Min AY, Han JH, Yang YJ, Kim H, Shin D (2020) Development and validation of LC-MS/MS method with QuEChERS clean-up for detecting cannabinoids in foods and dietary supplements. Food Additives Contaminants: Part A Chemistry, Analysis, Control, Exposure and Risk Assessment 37(9): 1413–1424. https://doi.org/10.1080/19440049.2020.1769200
  • Leghissa A, Smuts JP, Qiu C, Hildenbrand ZL, Schug KA (2018) Detection of cannabinoids and cannabinoid metabolites using gas chromatography with vacuum ultraviolet spectroscopy. Separation Science Plus 1(1): 37–42. https://doi.org/10.1002/sscp.201700005
  • Lim K, See YM, Lee J (2017) A systematic review of the effectiveness of medical Cannabis for psychiatric, movement and neurodegenerative disorders. Clinical Psychopharmacology and Neuroscience 15(4): 301–312. https://doi.org/10.9758/cpn.2017.15.4.301
  • Madej K, Chmiołek A, Szlachta K, Piekoszewski W (2021) HPLC-DAD analysis of hemp oil supplements for determination of four cannabinoids: cannabidiol, cannabidiolic acid, cannabinol and delta 9-tetrahydrocannabinol. Separations 8(12): 227. https://doi.org/10.3390/separations8120227
  • Manzoni OJ, Manduca A, Trezza V (2025) Therapeutic potential of cannabidiol polypharmacology in neuropsychiatric disorders. Trends in Pharmacological Sciences 46(2): 145–162. https://doi.org/10.1016/j.tips.2024.12.005
  • Mastinu A, Premoli M, Ferrari-Toninelli G, Tambaro S, Maccarinelli G, Memo M, Bonini SA (2018) Cannabinoids in health and disease: pharmacological potential in metabolic syndrome and neuroinflammation. Hormone Molecular Biology and Clinical Investigation 36(2): 20180013. https://doi.org/10.1515/hmbci-2018-0013
  • McGuire P, Robson P, Cubala WJ, Vasile D, Morrison PD, Barron R, Taylor A, Wright S (2018) Cannabidiol (CBD) as an adjunctive therapy in schizophrenia: a multicenter randomized controlled trial, American Journal of Psychiatry 175(3): 225–231. https://doi.org/10.1176/appi.ajp.2017.17030325
  • McLaren J, Swift W, Dillon P, Allsop S (2008) Cannabis potency and con­tamination: a review of the literature. Addiction 103(7): 1100–1109. https://doi.org/10.1111/j.1360-0443.2008.02230.x
  • Meng Q, Buchanan B, Zuccolo J, Poulin MM, Gabriele J, Baranowski DC (2018) A reliable and validated LC-MS/MS method for the simultaneous quantification of 4 cannabinoids in 40 consumer products. PLoS ONE 13(5): e0196396. https://doi.org/10.1371/journal.pone.0196396
  • Merone GM, Tartaglia A, Rossi S, Santavenere F, Bassotti E, D'Ovidio C, Bonelli M, Rosato E, de Grazia U, Zanardo A, Locatelli M, Savini F (2021) Fast liquid chromatography-tandem mass spectrometry method for the simultaneous determination of phytocannabinoids in oily based preparations. Journal of Pharmaceutical and Biomedical Analysis 203: 114174. https://doi.org/10.1016/j.jpba.2021.114174
  • Millar SA, Stone NL, Bellman ZD, Yates AS, England TJ, O'Sullivan SE (2019) A systematic review of cannabidiol dosing in clinical populations. British Journal of Clinical Pharmacology 85(9): 1888–1900. https://doi.org/10.1111/bcp.14038s
  • Miller I, Scheffer IE, Gunning B, Sanchez-Carpintero R, Gil-Nagel A, Perry MS, Saneto RP, Checketts D, Dunayevich E, Volker Knappertz V, GWPCARE2 Study Group (2020) Dose-ranging effect of adjunctive oral cannabidiol vs placebo on convulsive seizure frequency in Dravet syndrome: a randomized clinical trial. JAMA Neurology 77(5): 613–621. https://doi.org/10.1001/jamaneurol.2020.0073
  • Montoya Z, Conroy M, Vanden Heuvel BD, Pauli CS, Park SH (2020) Cannabis contaminants limit pharmacological use of cannabidiol. Frontiers in Pharmacology 11: 571832. https://doi.org/10.3389/fphar.2020.571832
  • Nahar L, Onder A, Sarker SD (2020) A review on the recent advances in HPLC, UHPLC and UPLC analyses of naturally occurring cannabinoids (2010–2019). Phytochemical Analysis 31(4): 413–457. https://doi.org/10.1002/pca.2906
  • Nielsen S, Germanos R, Weier M, Pollard J, Degenhardt L, Hall W, Buckley N, Farrell M (2018) The use of Cannabis and cannabinoids in treating symptoms of multiple sclerosis: a systematic review of reviews. Current Neurology and Neuroscience Reports 18(2): 8. https://doi.org/10.1007/s11910-018-0814-x
  • Omar J, Olivares M, Amigo JM, Etxebarria N (2014) Resolution of co-eluting compounds of Cannabis sativa in comprehensive two-dimensional gas chromatography/mass spectrometry detection with multivariate curve resolution-alternating least squares. Talanta 121: 273–280. https://doi.org/10.1016/j.talanta.2013.12.044
  • Palazzoli F, Citti C, Licata M, Vilella A, Manca L, Zoli M, Vandelli MA, Forni F, Cannazza G (2018) Development of a simple and sensitive liquid chromatography triple quadrupole mass spectrometry (LC–MS/MS) method for the determination of cannabidiol (CBD), Δ9-tetrahydrocannabinol (THC) and its metabolites in rat whole blood after oral administration of a single high dose of CBD. Journal of Pharmaceutical and Biomedical Analysis 150: 25–32. https://doi.org/10.1016/j.jpba.2017.11.054
  • Park SH, Pauli CS, Gostin EL, Staples SK, Seifried D, Kinney C, Vanden Heuvel BD (2022) Effects of short-term environmental stresses on the onset of cannabinoid production in young immature flowers of industrial hemp (Cannabis sativa L.). Journal of Cannabis Research 4(1): 1 https://doi.org/10.1186/s42238-021-00111-y
  • Peng H, Shahidi F (2021) Cannabis and cannabis edibles: a review. Journal of Agricultural and Food Chemistry 69(6): 1751–1774. https://doi.org/10.1021/acs.jafc.0c07472
  • Poleg S, Golubchik P, Offen D, Weizman A (2019) Cannabidiol as a suggested candidate for treatment of autism spectrum disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry 89: 90–96. https://doi.org/10.1016/j.pnpbp.2018.08.030
  • Radwan MM, Wanas AS, Gul W, Ibrahim EA, ElSohly MA (2023) Isolation and characterization of impurities in commercially marketed Δ8-THC products. Journal of Natural Products 86(4): 822–829.https://doi.org/10.1021/acs.jnatprod.2c01008
  • Raslan-Jaramillo JJ, Ríos-Gajardo GA, Avello MA, de Diego MG (2024) Determination of cannabinoids in Cannabis sativa oil and infused ice cream by LC-DAD method. Journal of AOAC International 107(1): 140–145. https://doi.org/10.1093/jaoacint/qsad122
  • Rice J, Cameron M (2018) Cannabinoids for treatment of MS symptoms: state of the evidence. Current Neurology and Neuroscience Reports 18(8): 50. https://doi.org/10.1007/s11910-018-0859-x
  • Rudroff T, Honce JM (2017) Cannabis and multiple sclerosis – the way forward. Frontiers in Neurology 8: 299. https://doi.org/10.3389/fneur.2017.00299
  • Schwarzenberg A, Carpenter H, Wright C, Bayazeid O, Brokl M (2022) Characterizing the degradation of cannabidiol in an e-liquid formulation. Scientific Reports 12(1): 20058. https://doi.org/10.1038/s41598-022-23910-6
  • Seo C, Jeong M, Lee S, Kim EJ, Rho S, Cho M, Lee YS, Hong J (2022) Thermal decarboxylation of acidic cannabinoids in Cannabis species: identification of transformed cannabinoids by UHPLC-Q/TOF–MS. Journal of Analytical Science and Technology 13: 42. https://doi.org/10.1186/s40543-022-00351-4
  • Shuda SA, Folger JF, Spargo E, Logan BK (2024) Development and validation of a quantitative method for the analysis of delta‐9‐tetrahydrocannabinol (delta‐9‐THC), delta‐8‐tetrahydrocannabinol (delta‐8‐THC), delta‐9‐tetrahydrocannabinolic acid (THCA), and cannabidiol (CBD) in botanicals, edibles, liquids, oils, waxes, and bath products by gas chromatography mass spectrometry (GC/MS). Journal of Forensic Sciences 69(5): 1718–1729. https://doi.org/10.1111/1556-4029.15574
  • Singh K, Bhushan B, Chanchal DK, Sharma SK, Rani K, Yadav MK, Porwal P, Kumar S, Sharma A, Virmani T, Kumar G, Noman AA (2023) Emerging therapeutic potential of cannabidiol (CBD) in neurological disorders: a comprehensive review. Behavioural Neurology 2023(1): 8825358. https://doi.org/10.1155/2023/8825358
  • Sirikantaramas S, Taura F (2017) Cannabinoids: biosynthesis and biotechnological applications. In: Cannabis sativa L. – Botany and Biotechnology. Springer International Publishing, University of Illinois Press, Champaign, Illinois, United States, 183–206. https://doi.org/10.1007/978-3-319-54564-6_8
  • Sobolesky PM, Smith BE, Hubbard JA, Stone J, Marcotte TD, Grelotti DJ, Grant I, Fitzgerald RL (2019) Validation of a liquid chromatography-tandem mass spectrometry method for analyzing cannabinoids in oral fluid. Clinica Chimica Acta 491: 30–38. https://doi.org/10.1016/j.cca.2019.01.002
  • Starowicz K, Finn DP (2017) Cannabinoids and pain: sites and mechanisms of action. Advances in Pharmacology 80: 437–475. https://doi.org/10.1016/bs.apha.2017.05.003
  • Stefkov G, Cvetkovikj-Karanfilova I, Stoilkovska-Gjorgievska V, Trajkovska A, Geskovski N, Karapandzova M, Kulevanova S (2022) Analytical techniques for phytocannabinoid profiling of Cannabis and Cannabis-based products – a comprehensive review. Molecules 27: 975. https://doi.org/10.3390/molecules27030975
  • Szaflarski JP, Bebin EM, Cutter G, DeWolfe J, Dure LS, Gaston TE, Kankirawatana P, Liu Y, Singh R, Standaert DG, Thomas AE, Ver Hoef LW (2018) Cannabidiol improves frequency and severity of seizures and reduces adverse events in an open-label add-on prospective study. Epilepsy Behavior 87: 131–136. https://doi.org/10.1016/j.yebeh.2018.07.020
  • Tafelski S, Häuser W, Schäfer M (2016) Efficacy, tolerability, and safety of cannabinoids for chemotherapy-induced nausea and vomiting – a systematic review of systematic reviews. Der Schmerz 30(1): 14–24. https://doi.org/10.1007/s00482-015-0092-3
  • Tahir MN, Shahbazi F, Rondeau-Gagné S, Trant JF (2021) The biosynthesis of the cannabinoids. Journal of Cannabis Research 3(1): 7. https://doi.org/10.1186/s42238-021-00062-4
  • Takashina S, Igarashi Y, Takahashi M, Kondo Y, Inoue K (2020) Screening method for the quality evaluation of cannabidiols in water-based products using liquid chromatography tandem mass spectrometry Analytical Sciences 36(11): 1427–1430. https://doi.org/10.2116/analsci.20N015
  • Takashina S, Takahashi M, Morimoto K, Inoue K (2022) LC-MS/MS assay for the measurement of cannabidiol profiling in CBD oil from Japanese market and application for convertible tetrahydrocannabinol in acetic acid condition. Chemical and Pharmaceutical Bulletin 70(2): 169–174. https://doi.org/10.1248/cpb.c21-00901
  • Thomson BJ, Hanna S, Schwarzenberg A, Kiani P, Bizzotto D, Kennepohl P, Davies A, Roggen M, Sammis GM (2023) CBD hydroxyquinone photo-isomerises to a highly reactive intermediate. Scientific Reports 13(1): 6967. https://doi.org/10.1038/s41598-023-33815-7
  • Tolomeo F, Russo F, Vandelli MA, Biagini G, Capriotti AL, Laganà A, Carbone L, Gigli G, Cannazza G, Citti C (2021) HPLC-UV-HRMS analysis of cannabigerovarin and cannabigerobutol, the two impurities of cannabigerol extracted from hemp. Journal of Pharmaceutical and Biomedical Analysis 203: 114215. https://doi.org/10.1016/j.jpba.2021.114215
  • UNODC (2007) The emergence of "new cannabis" and the reassessment of health risks. Chapter 2.3 in World drugs report, 2006, United Na­tions Office on Drugs and Crime, Vienna.
  • Valdeolivas S, Navarrete C, Cantarero I, Bellido ML, Muñoz E, Sagredo O (2015) Neuroprotective properties of cannabigerol in Huntington's disease: studies in R6/2 mice and 3-nitropropionate-lesioned mice. Neurotherapeutics 12(1): 185–199. https://doi.org/10.1007/s13311-014-0304-z
  • Vlad RA, Farczadi L, Toma CM, Imre S, Antonoaea P, Redal EM, Muntean DA, Ciurba A (2021) Cannabidiol content evaluation in commercial dietary supplements and stability in oil vehicle. Studia Universitatis Babes-Bolyai, Chemia 66(2): 299–308.
  • Wang M, Wang YH, Avula B, Radwan MM, Wanas AS, Mehmedic Z, van Antwerp J, ElSohly MA, Khan IA (2017) Quantitative determination of cannabinoids in Cannabis and Cannabis products using ultra‐high‐performance supercritical fluid chromatography and diode array/mass spectrometric detection. Journal of Forensic Sciences 62(3): 602–611. https://doi.org/10.1111/1556-4029.13341
  • Wodak A, Reinarman C, Cohen PDA (2002) Cannabis control: costs outweigh the benefits. British Medical Journal 324(7329): 105–106. https://doi.org/10.1136/bmj.324.7329.105
  • Xiong Y, Lim CS (2021) Understanding the modulatory effects of cannabidiol on Alzheimer's disease. Brain Sciences 11(9): 1211. https://doi.org/10.3390/brainsci11091211